News
Sanofi-Synthelabo has upgraded its full-year share earnings guidance for 2003, despite its plans to spend more on R&D.
Doctors and health unions have expressed their concerns about the effect of new fast track surgery centres on the rest of the NHS.
GlaxoSmithKline has cut prices of its HIV/AIDS drugs for developing countries by nearly half following intense pressure from campaigners and...
International sales of several key drugs helped Bristol-Myers Squibb to minimise the effects of continued US generic competition in the first quarter...
Nearly three in five doctors would like to be able to charge their patients for home visits, according to a new survey.
The Government is to modify one of its key waiting times targets after sustained protests about its inability to reflect the needs of all patients.
The UK Government has promised faster access to new and experimental treatments for cancer patients through a new Oxford-based research centre.
AstraZeneca says new data shows its asthma treatment Symbicort outperformed rival treatment GlaxoSmithKline Seretide, in their first ever head-to-...
Global healthcare communications agency Euro RSCG Life has acquired Money Syner Communications to create what it says will be the UK biggest...
Pfizer spots potential of Organon atypical antipsychotic
